Phase I - II Study of Doxil in Combination With Daily Oral Cyclophosphamide and Trastuzumab in HER-2/Neu Positive Patients With Metastatic Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin liposomal; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2017 Biomarkers information updated
- 19 Jul 2012 Actual end date (1 feb 2011) added as reported by ClinicalTrials.gov.
- 11 Oct 2010 Planned end date changed from 1 Jul 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.